Texas Biomed researchers complete critical preclinical study to advance potential tuberculosis therapy toward human clinical trials
SAN ANTONIO (March 31, 2023) — Texas Biomed scientists have identified a promising way to help fight tuberculosis (TB), a disease that still kills nearly 2 million people annually. The…
SAN ANTONIO (December 19, 2022) ā A Sudan ebolavirus vaccine and antibody therapeutic tested at Texas Biomedical Research Institute have been sent to Uganda as part of efforts to control the…
The complex will provide brand new indoor/outdoor housing for up to 800 nonhuman primates and advanced veterinary care capabilities.
Erratic, involuntary movements often emerge as a side effect of the primary medication used to treat Parkinsonās disease. Now, Texas Biomed researchers and their collaborators have shown a compound can…